|
Jeani Delagardelle is a Managing Director and leads our
medical device practice. Jeani joined Sprout in August 2000
and became General Partner in July 2001. Previously, she was
a General Partner at Weiss, Peck & Greer Venture Partners
where she focused on healthcare/technology investments. Before joining
Weiss, Peck & Greer Venture Partners, Jeani spent 15 years
in senior marketing, sales, business development and general
manager positions in the healthcare industry. Specifically,
she was Vice President of Global Marketing for Target
Therapeutics (acquired by Boston Scientific for $1.1B) and
spent nine years with the Medi-tech division of Boston
Scientific in several senior management roles. In addition,
Jeani served as Director of Business Operations for Roche
Laboratories and Director of Global Marketing for Cell Pro,
Inc. Jeani attended University of California at Irvine (M.B.A.)
and Occidental College (A.B.).
Board Seats:
Access Closure,
Direct Flow,
Intrinsic Therapeutics,
ReShape Medical,
Spiracur,
Spiration,
World Heart Corporation (WHRT)
Contact Information:
jeani@nlvpartners.com
(650) 234-2700
|
 |
